Reported 2 days ago
Abbott Laboratories (ABT) stands out among innovative healthcare stocks as it continues to grow despite rising healthcare costs in the U.S. Significant trends affecting the industry include the influence of tariffs on U.S.-China relations and the increasing reliance on Chinese manufacturing for research and production. Abbott is well-positioned with a strong product portfolio in medical devices and pharmaceuticals, projecting a robust organic sales growth for 2025. While the company holds promise for long-term investment, AI stocks may offer greater short-term returns.
Source: YAHOO